Legacy Capital Group California, Inc. Catalent, Inc. Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 9,631 shares of CTLT stock, worth $569,192. This represents 0.19% of its overall portfolio holdings.
Number of Shares
9,631Holding current value
$569,192% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding CTLT
# of Institutions
512Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$907 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$440 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$378 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$267 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...